Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells

Abstract

Cyclooxygenase-2 (COX-2) expression has been detected in human hepatoma cell lines and in human hepatocellular carcinoma (HCC); however, the contribution of COX-2 to the development of HCC remains controversial. COX-2 expression is higher in the non-tumoral tissue and inversely correlates with the differentiation grade of the tumor. COX-2 expression depends on the interplay between different cellular pathways involving both transcriptional and post-transcriptional regulation. The aim of this work was to assess whether COX-2 could be regulated by microRNAs in human hepatoma cell lines and in human HCC specimens since these molecules contribute to the regulation of genes implicated in cell growth and differentiation. Our results show that miR-16 silences COX-2 expression in hepatoma cells by two mechanisms: a) by binding directly to the microRNA response element (MRE) in the COX-2 3′-UTR promoting translational suppression of COX-2 mRNA; b) by decreasing the levels of the RNA-binding protein Human Antigen R (HuR). Furthermore, ectopic expression of miR-16 inhibits cell proliferation, promotes cell apoptosis and suppresses the ability of hepatoma cells to develop tumors in nude mice, partially through targeting COX-2. Moreover a reduced miR-16 expression tends to correlate to high levels of COX-2 protein in liver from patients affected by HCC. Our data show an important role for miR-16 as a post-transcriptional regulator of COX-2 in HCC and suggest the potential therapeutic application of miR-16 in those HCC with a high COX-2 expression.

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1

“…58 Interestingly, several of the tumor types which, in addition to BC and GC, show ErbB-2 gene amplification or protein overexpression, display low levels of miR-16. 59–65 Given that miR-16 was found to act as a tumor suppressor in these cancers, 59–65 our findings raise the exciting possibility that ErbB-2 inhibition of miR-16 expression may be a common mechanism underlying ErbB-2-driven cancer growth. TZ has been found to regulate the expression of other miRNAs, which mediate its antiproliferative effects in BC.…”

miRNA-15a/16: As Tumor Suppressors and More

“…Cytoplasmic HuR can also bind to miR-16 and downregulate it. (This mechanism may also exist in hepatoma [5]). In the same research, the mRNA of Bcl-2 and VEGF, which are also the targets of miR-16, showed to contain ARE too and could be protected from miR-16 mediated decay by HuR.…”

MicroRNA-101 Inhibits Cell Proliferation, Invasion, and Promotes Apoptosis by Regulating Cyclooxygenase-2 in Hela Cervical Carcinoma Cells

“…COX-2 expression depends on the interplay between different cellular pathways involving both transcriptional and post-transcriptional regulation (Agra Andrieu et al, 2012). Normally absent in most cells, COX-2 (PTGS2) expression is rapidly induced by proinflammatory and growth-associated stimuli.…”